Recall of Over 110,000 Rich's Ice Cream Bars Due to Listeria Concerns

Over 110,000 Rich's ice cream bars are recalled due to potential Listeria contamination, posing health risks. Consumers should check their products and avoid consumption.
In a recent safety alert, more than 110,000 ice cream bars produced by Rich's Ice Cream Co. have been voluntarily recalled due to potential contamination with Listeria monocytogenes, a harmful bacterium. The recall includes products sold across 23 states in the U.S. and also in Nassau, Bahamas. The affected ice creams were packaged individually in plastic bags and distributed in master cases, and bear Lot numbers ranging from 24351 to 25156.
The impacted products include a variety of flavors and types such as Chocolate Crunch Cake Bars, Strawberry Shortcake Bars, Rich Bars, Crumbled Cookie Bars, Orange Cream Bars, Fudge Frenzy Bars, Cotton Candy Twirl Bars, and Sour Blue Raspberry and Cherry Bars, as well as Watermelon Bars. Consumers are advised to check the packaging for these Lot numbers and avoid consuming any affected items.
The recall was initiated by Rich's Ice Cream, based in West Palm Beach, Florida, along with the U.S. Food and Drug Administration (FDA). The FDA classified it as a Class II recall, indicating that exposure to the product could cause temporary or reversible health effects. No illnesses have been reported so far, but investigations are ongoing.
Listeria infection, or listeriosis, can cause serious health complications, especially for pregnant women, newborns, older adults, and individuals with weakened immune systems. Symptoms generally include diarrhea and vomiting. According to the CDC, about 1,600 people are infected annually in the U.S., with approximately 260 fatalities.
FDA and the company urge consumers to refrain from eating these recalled ice cream bars and to contact Rich's Ice Cream via their website for further information and assistance. For complete details, refer to the official recall notice on the FDA website.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Udenafil Shows Promising Results in Improving Exercise Capacity in Fontan Patients with Reduced Baseline Function
A post-hoc analysis of the FUEL trial reveals that udenafil significantly improves exercise capacity in Fontan patients with reduced baseline function, offering promising avenues for targeted therapy.
Herpes Simplex Virus-1 Infection Linked to Increased Alzheimer's Disease Risk
Emerging evidence suggests that herpes simplex virus-1 (HSV-1) infection may increase the risk of Alzheimer's disease, with antiviral therapy potentially offering protective benefits.



